FR3009496B1 - Formes multiparticulaires a liberation prolongee, procede de leurs preparations et compositions les contenant pour le traitement et/ou prevention de la cyctinurie - Google Patents
Formes multiparticulaires a liberation prolongee, procede de leurs preparations et compositions les contenant pour le traitement et/ou prevention de la cyctinurieInfo
- Publication number
- FR3009496B1 FR3009496B1 FR1301924A FR1301924A FR3009496B1 FR 3009496 B1 FR3009496 B1 FR 3009496B1 FR 1301924 A FR1301924 A FR 1301924A FR 1301924 A FR1301924 A FR 1301924A FR 3009496 B1 FR3009496 B1 FR 3009496B1
- Authority
- FR
- France
- Prior art keywords
- cyctinuria
- multiparticular
- prevention
- preparation
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000002035 prolonged effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1301924A FR3009496B1 (fr) | 2013-08-12 | 2013-08-12 | Formes multiparticulaires a liberation prolongee, procede de leurs preparations et compositions les contenant pour le traitement et/ou prevention de la cyctinurie |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1301924A FR3009496B1 (fr) | 2013-08-12 | 2013-08-12 | Formes multiparticulaires a liberation prolongee, procede de leurs preparations et compositions les contenant pour le traitement et/ou prevention de la cyctinurie |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3009496A1 FR3009496A1 (fr) | 2015-02-13 |
FR3009496B1 true FR3009496B1 (fr) | 2016-02-05 |
Family
ID=49989820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1301924A Active FR3009496B1 (fr) | 2013-08-12 | 2013-08-12 | Formes multiparticulaires a liberation prolongee, procede de leurs preparations et compositions les contenant pour le traitement et/ou prevention de la cyctinurie |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR3009496B1 (fr) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2061394B1 (es) * | 1993-02-05 | 1995-06-16 | Robert S A Lab | Procedimiento de fabricacion de un granulado de citrato potasico con cesion retardada. |
EP1970066A1 (fr) * | 2007-03-12 | 2008-09-17 | Medice Arzneimittel Pütter GmbH & Co. KG | Composition pharmaceutique destinée au traitement d'une hyperacidification du sang |
FR2967578B1 (fr) * | 2010-11-18 | 2012-12-28 | Advicenne Pharma | Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie |
-
2013
- 2013-08-12 FR FR1301924A patent/FR3009496B1/fr active Active
Also Published As
Publication number | Publication date |
---|---|
FR3009496A1 (fr) | 2015-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL264049A (en) | Compounds, preparations and methods for treating the disease | |
MA45192A (fr) | Traitement d'association | |
MA55629A (fr) | Compositions d'anticorps pour le traitement de tumeurs | |
IL264156A (en) | Compounds, preparations and methods for treating the disease | |
MA45481A (fr) | Utilisation d'exosomes pour le traitement de maladies | |
HK1246296A1 (zh) | 多環氨基甲酰基吡啶酮化合物和其用於治療hiv感染的用途 | |
MA44083A (fr) | Composés de biarylmonobactame pour le traitement d'infections bactériennes | |
HK1223615A1 (zh) | 多環氨基甲酰基吡啶酮化合物和其用於治療 感染的用途 | |
MA52906A (fr) | Procédé de préparation d'amg 416 | |
MA43574A (fr) | Compositions ayant des amplificateurs de perméation pour l'administration de médicaments | |
HK1220324A1 (zh) | 用於治療血管緊張素相關疾病的方法、化合物和組合物 | |
MA44875A (fr) | Compositions pour le traitement de troubles acido-basiques | |
FR3011467B1 (fr) | Composes et compositions comprenant de tels composes pour la prevention ou le traitement des dyslipidemies | |
ZA201704957B (en) | Composition for the treatment of hepatic veno-occlusive disease | |
FR3029778B1 (fr) | Composition cosmetique comprenant des alpha-olefine sulfonates lineaires, des tensioactifs anioniques et des tensioactifs non ioniques et/ou ampho-teres, et procede de traitement cosmetique | |
FR20C1044I2 (fr) | Triazines pour le traitement des infections protozoïques | |
EA201690783A1 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
MA45552A (fr) | Compositions destinées au traitement de l'amylose | |
MA46999A (fr) | Oligonucléotides modifiés pour traiter la polykystose rénale | |
FR2999191B1 (fr) | Souches probiotiques pour le traitement et/ou la prevention de la diarrhee | |
FR3022139B1 (fr) | Nouvelles compositions pour le traitement des rougeurs cutanees et de la rosacee | |
FR3020758B1 (fr) | Composition pour ameliorer l'hygiene buco-dentaire | |
IN2014MN01733A (fr) | ||
FR3015285B1 (fr) | Formulation pour le traitement des cheveux | |
PL3124048T3 (pl) | Kompozycja do stosowania doustnego w leczeniu choroby lub dolegliwości związanych z odpływem żołądkowo-przełykowym |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 5 |
|
PLFP | Fee payment |
Year of fee payment: 6 |
|
PLFP | Fee payment |
Year of fee payment: 8 |
|
PLFP | Fee payment |
Year of fee payment: 10 Year of fee payment: 9 |
|
PLFP | Fee payment |
Year of fee payment: 11 |
|
PLFP | Fee payment |
Year of fee payment: 12 |